131 related articles for article (PubMed ID: 36502788)
21. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
Yang W; Chen YH; Liu H; Qu HD
Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
[TBL] [Abstract][Full Text] [Related]
22. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802
[TBL] [Abstract][Full Text] [Related]
23. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway.
Yang JM; Huang HM; Cheng JJ; Huang CL; Lee YC; Chiou CT; Huang HT; Huang NK; Yang YC
Toxicology; 2018 Dec; 410():65-72. PubMed ID: 30205152
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
25. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
Marchetti B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
[TBL] [Abstract][Full Text] [Related]
26. Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Yue Y; Qiao B; Jiang X
Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):32-36. PubMed ID: 32359380
[TBL] [Abstract][Full Text] [Related]
27. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
[TBL] [Abstract][Full Text] [Related]
29. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.
Vallée A; Vallée JN; Lecarpentier Y
Aging (Albany NY); 2021 Apr; 13(7):10796-10813. PubMed ID: 33848261
[TBL] [Abstract][Full Text] [Related]
30. Silencing RNF13 Alleviates Parkinson's Disease - Like Problems in Mouse Models by Regulating the Endoplasmic Reticulum Stress-Mediated IRE1α-TRAF2-ASK1-JNK Pathway.
Ji M; Niu S; Guo J; Mi H; Jiang P
J Mol Neurosci; 2020 Dec; 70(12):1977-1986. PubMed ID: 32617872
[TBL] [Abstract][Full Text] [Related]
31. Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice.
Zhu J; Gao W; Shan X; Wang C; Wang H; Shao Z; Dou S; Jiang Y; Wang C; Cheng B
Brain Res; 2020 Jan; 1726():146493. PubMed ID: 31586624
[TBL] [Abstract][Full Text] [Related]
32. l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease.
Raj K; Gupta GD; Singh S
Drug Chem Toxicol; 2022 Sep; 45(5):2097-2108. PubMed ID: 34210222
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
34. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
[TBL] [Abstract][Full Text] [Related]
35. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
36. Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced Parkinson's disease by promoting Wnt/β-catenin signaling pathway.
Cao W; Dong Y; Zhao W; Lu X; Sun L
J Chem Neuroanat; 2019 Jul; 98():63-70. PubMed ID: 30978489
[TBL] [Abstract][Full Text] [Related]
37. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
[TBL] [Abstract][Full Text] [Related]
38. Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease.
Ruan S; Xie J; Wang L; Guo L; Li Y; Fan W; Ji R; Gong Z; Xu Y; Mao J; Xie J
Front Pharmacol; 2023; 14():1088957. PubMed ID: 36817162
[No Abstract] [Full Text] [Related]
39. Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson's disease.
Dai TL; Zhang C; Peng F; Niu XY; Hu L; Zhang Q; Huang Y; Chen L; Zhang L; Zhu W; Ding YQ; Song NN; Liao M
Exp Ther Med; 2014 Aug; 8(2):384-390. PubMed ID: 25009587
[TBL] [Abstract][Full Text] [Related]
40. Effect of Roucongrong (Herba Cistanches Deserticolae) decoction on the substantia nigra through Wnt/β-catenin signaling pathway in rats with Parkinson's disease induced by 6-hydroxydopamine hydrochloride.
Xu Q; Qin W; Wu FZ; Lin Y; Hong LT; Chen D; Hu XF; Cai J
J Tradit Chin Med; 2021 Oct; 41(5):762-770. PubMed ID: 34708635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
